In This Article:
As the European market continues to navigate mixed economic signals, with inflation concerns and varying GDP growth across major economies, investors are increasingly focusing on companies that demonstrate resilience and potential for growth. In this context, stocks with high insider ownership can be particularly attractive as they often indicate strong internal confidence in the company's future prospects.
Top 10 Growth Companies With High Insider Ownership In Europe
| Name | Insider Ownership | Earnings Growth |
| TF Bank (OM:TFBANK) | 15.6% | 20% |
| Elicera Therapeutics (OM:ELIC) | 27.8% | 97.2% |
| Vow (OB:VOW) | 12.9% | 120.9% |
| Pharma Mar (BME:PHM) | 11.9% | 40.1% |
| CD Projekt (WSE:CDR) | 29.7% | 39.4% |
| Bergen Carbon Solutions (OB:BCS) | 12% | 50.8% |
| XTPL (WSE:XTP) | 27.9% | 118% |
| Ortoma (OM:ORT B) | 27.7% | 73.4% |
| Elliptic Laboratories (OB:ELABS) | 22.6% | 89.9% |
| Circus (XTRA:CA1) | 26% | 51.4% |
Here's a peek at a few of the choices from the screener.
Vastned Belgium
Simply Wall St Growth Rating: ★★★★★☆
Overview: Vastned Belgium is a public regulated real estate company (RREC) listed on Euronext Brussels, with a market capitalization of €545.13 million.
Operations: Vastned Belgium focuses on managing and investing in retail properties across prime locations, generating revenue through leasing activities.
Insider Ownership: 18.9%
Vastned Belgium shows promising growth potential, with earnings and revenue forecasted to grow significantly at 50.7% and 46.9% per year, respectively, outpacing the Belgian market averages. Despite recent declines in sales and net income for 2024, the company remains a strong contender in its sector with inclusion in the ASCX AMS Small Cap Index. However, its dividend sustainability is questionable due to insufficient free cash flow coverage and debt not well covered by operating cash flow.
-
Unlock comprehensive insights into our analysis of Vastned Belgium stock in this growth report.
-
Our valuation report unveils the possibility Vastned Belgium's shares may be trading at a premium.
Stemmer Imaging
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Stemmer Imaging AG offers machine vision technology for various applications globally, with a market cap of €357.50 million.
Operations: The company generates revenue primarily from its machine vision technology segment, amounting to €113.27 million.
Insider Ownership: 15.6%
Stemmer Imaging's earnings are forecast to grow significantly at 41% annually, surpassing the German market average. However, its revenue growth of 11.2% per year trails behind the ideal high-growth threshold but still exceeds the market rate. Despite a decline in profit margins from 11.6% to 7.2%, there is no substantial insider trading activity reported recently, indicating stability in insider sentiment amidst these mixed performance metrics.